8 studies found for:    telintra
Show Display Options
Rank Status Study
1 Terminated Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: ezatiostat hydrochloride (Telintra®)
2 Terminated Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Intervention: Drug: Ezatiostat Hydrochloride
3 Terminated Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: ezatiostat hydrochloride (Telintra®)
4 Terminated Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: ezatiostat hydrochloride (Telintra®)
5 Completed Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Ezatiostat Hydrochloride
6 Completed Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome
Interventions: Drug: Ezatiostat Hydrochloride;   Drug: Lenalidomide (Revlimid®)
7 Completed Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Ezatiostat Hydrochlorine
8 Completed Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: TLK199 HCl Liposomes for Injection

Indicates status has not been verified in more than two years